TFRC and neoplasm: For instance, an anti-TfR antibody has been used for tumour-directed delivery of immunotoxins (Wang et al, 2022), and TfR-directed chimeric antigen receptor (CAR) T-cells are effective in mouse models of T-cell acute lymphoblastic leukemia (Guo et al, 2021).